Efficacy of cladribine tablets 3.5mg/kg in patients with relapsing multiple sclerosis aged above and below 45 years; CLARITY and CLARITY Extension

被引：0
|
作者：
Giovannoni, G. [1 ]
Rammohan, K. [2 ]
Cook, S. [3 ]
Soelberg-Sorensen, P. [4 ]
Vermersch, P. [5 ]
Keller, B. [6 ]
Di Cantogno, E. Verdun [6 ]
机构：
[1] Queen Mary Univ London, Blizard Inst, London, England
[2] Univ Miami Hlth Syst, MS Ctr Excellence, Miami, FL USA
[3] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[4] Copenhagen Univ Hosp, Danish MS Ctr, Dept Neurol, Copenhagen, Denmark
[5] Univ Lille, Lille, France
[6] Merck KGaA, Darmstadt, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1243
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [1] Efficacy of cladribine tablets 3.5 mg/kg in patients with relapsing multiple sclerosis aged above and below 45 years; clarity and clarity extension
    Giovannoni, G.
    Rammohan, K.
    Cook, S.
    Soelberg-Sorensen, P.
    Vermersch, P.
    Keller, B.
    di Cantogno, E. Verdun
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [2] An exploratory analysis of the efficacy of cladribine tablets 3.5mg/kg in patients with relapsing multiple sclerosis stratified according to age above and below 45 years in the CLARITY study
    Giovannoni, G.
    Rammohan, K.
    Cook, S.
    Soelberg-Sorensen, P.
    Vermersch, P.
    Keller, B.
    di Cantogno, E. Verdun
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 681 - 682
  • [3] An Exploratory Analysis of the Efficacy of Cladribine Tablets 3.5 mg/kg in Patients with Relapsing Multiple Sclerosis Stratified According to Age Above and Below 45 Years in the CLARITY Study
    Giovannoni, G.
    Rammohan, K.
    Cook, S.
    Soelberg-Sorensen, P.
    Vermersch, P.
    King, J.
    Keller, B.
    di Cantogno, E. Verdun
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 465 - 466
  • [4] Innate immune cell counts in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) treated with cladribine tablets 3.5mg/kg in CLARITY and CLARITY extension
    Soelberg-Sorensen, P.
    Dangond, F.
    Hicking, C.
    Giovannoni, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 528 - 528
  • [5] Year-by-year lymphopenia rates in patients with relapsing multiple sclerosis (RMS) treated with cladribine tablets 3.5mg/kg in CLARITY and re-treated in CLARITY Extension
    Cook, S.
    Comi, G.
    Giovannoni, G.
    Rieckmann, P.
    Soelberg-Sorensen, P.
    Vermersch, P.
    Dangond, F.
    Hicking, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 195 - 196
  • [6] Year-by-year lymphopenia rates in patients with relapsing multiple sclerosis (RMS) treated with cladribine tablets 3.5mg/kg in CLARITY and re-treated in CLARITY Extension
    Cook, Stuart
    Comi, Giancarlo
    Giovannoni, Gavin
    Rieckmann, Peter
    Soelberg-Sorensen, Per
    Vermersch, Patrick
    Dangond, Fernando
    Hicking, Christine
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP11 - NP11
  • [7] Absolute lymphocyte counts in patients with relapsing multiple sclerosis (RMS) treated with cladribine tablets 3.5 mg/kg in the CLARITY and CLARITY Extension studies
    Soelberg-Sorensen, P.
    Dangond, F.
    Hicking, C.
    Giovannoni, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 412 - 412
  • [8] Absolute lymphocyte count recovery in patients with relapsing-remitting multiple sclerosis (RRMS) treated with cladribine tablets 3.5 mg/kg in CLARITY and CLARITY Extension
    Soelberg-Sorensen, Per
    Dangond, Fernando
    Hicking, Christine
    Giovannoni, Gavin
    NEUROLOGY, 2017, 88
  • [9] Innate immune cell counts in patients with relapsing-remitting multiple sclerosis (RRMS) treated with cladribine tablets 3.5 mg/kg in CLARITY and CLARITY extension
    Soelberg-Sorensen, P.
    Dangond, F.
    Hicking, C.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 598 - 599
  • [10] Absolute lymphocyte count recovery in patients with relapsing-remitting multiple sclerosis (RRMS) treated with cladribine tablets 3.5 mg/kg in CLARITY and CLARITY Extension
    Soelberg-Sorensen, Per
    Dangond, Fernando
    Hicking, Christine
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP12 - NP12
12345